Bryan Lim

Bryan Lim, Khazanah's head of impact programme and CEO of Jelawang Capital, is stepping down after 20 years at the sovereign wealth fund. He stepped down effective June 30, 2025, for "a short sabbatical." Jelawang Capital, a RM1 billion national fund-of-funds, was launched in October 2024 to accelerate Malaysia's venture capital ecosystem through initiatives including the Emerging Fund Managers' Programme and the Regional Managers' Initiative.

Mr Lim was a key member of the team that set up Khazanah's first foreign office in Beijing in 2008 and was subsequently appointed Head of China in 2017. After serving 13 years overseas, he returned to Malaysia in 2021 to assume his current role in Khazanah. He is appointed to the Board of IHH Healthcare Berhad in February 2023.

Bryan Lim holds a Master of Business Administration from MIT Sloan Fellows @ MIT Sloan School of Management (2013-2014). Prior to Khazanah, he was with Ernst & Young, Rating Agency Malaysia Bhd and ECM Libra Securities Sdn Bhd.

Career History

• Chief Executive Officer, Jelawang Capital (2024–2025)
• Executive Director, Head of Dana Impak and Impact Investments, Khazanah Nasional Berhad (2021–2025)
• Head of China, Khazanah Nasional Berhad (2017–2021)
• Key team member, Beijing foreign office establishment, Khazanah Nasional Berhad (2008)
• Roles at Ernst & Young, Rating Agency Malaysia Bhd, and ECM Libra Securities Sdn Bhd (prior to Khazanah)

What Bryan Lim could bring to his next role: With two decades of sovereign wealth fund experience, deep expertise in impact investing and healthcare sector board governance, and a track record of international expansion (particularly in China), Lim is positioned to drive sophisticated capital allocation and institutional development in venture capital or emerging market investment roles. His leadership of Jelawang Capital—a landmark catalytic initiative supporting Malaysia's startup ecosystem—demonstrates capability in building support infrastructure for under-served investment markets.